Monthly information on share capital and company voting rights
Cellectis has released its monthly share capital and voting rights update as of January 31, 2025, in accordance with Article 223-16 of the French financial markets authority's General Regulation. The company reported a total of 100,093,873 shares in capital and 88,660,571 voting rights. This information was disclosed for the Euronext Growth market, where Cellectis trades under the ISIN code FR0010425595.
Cellectis ha pubblicato il suo aggiornamento mensile sul capitale azionario e sui diritti di voto al 31 gennaio 2025, in conformità con l'Articolo 223-16 del Regolamento generale dell'autorità dei mercati finanziari francese. L'azienda ha riportato un totale di 100.093.873 azioni in capitale e 88.660.571 diritti di voto. Queste informazioni sono state divulgate per il mercato Euronext Growth, dove Cellectis opera con il codice ISIN FR0010425595.
Cellectis ha publicado su informe mensual sobre el capital accionario y los derechos de voto al 31 de enero de 2025, de acuerdo con el Artículo 223-16 del Reglamento General de la autoridad de los mercados financieros de Francia. La empresa reportó un total de 100.093.873 acciones en capital y 88.660.571 derechos de voto. Esta información se divulgó para el mercado Euronext Growth, donde Cellectis opera bajo el código ISIN FR0010425595.
Cellectis는 2025년 1월 31일 기준으로 프랑스 금융당국의 일반 규정 제223-16조에 따라 월간 주식 자본 및 의결권 업데이트를 발표하였습니다. 이 회사는 총 100,093,873주의 자본과 88,660,571개의 의결권을 보고했습니다. 이 정보는 Cellectis가 ISIN 코드 FR0010425595로 거래되는 Euronext Growth 시장에 공개되었습니다.
Cellectis a publié sa mise à jour mensuelle sur le capital social et les droits de vote au 31 janvier 2025, conformément à l'Article 223-16 du Règlement général de l'autorité des marchés financiers française. La société a déclaré un total de 100 093 873 actions en capital et 88 660 571 droits de vote. Cette information a été divulguée pour le marché Euronext Growth, où Cellectis est coté sous le code ISIN FR0010425595.
Cellectis hat sein monatliches Update zum Aktienkapital und zu den Stimmrechten zum 31. Januar 2025 veröffentlicht, gemäß Artikel 223-16 der allgemeinen Regelung der französischen Finanzaufsichtsbehörde. Das Unternehmen berichtete von insgesamt 100.093.873 Aktien im Kapital und 88.660.571 Stimmrechten. Diese Informationen wurden für den Euronext Growth Markt bekannt gegeben, wo Cellectis unter der ISIN-Nummer FR0010425595 handelt.
- None.
- None.
(Article 223-16 of General Regulation of the French financial markets authority)
PARIS, Feb. 04, 2025 (GLOBE NEWSWIRE) --
Listing market: Euronext Growth
ISIN code: FR0010425595
| Date | Total number of shares in the capital | Total number of voting rights |
| 01/31/2025 | 100,093,873 | 88,660,571 |
For further information on Cellectis, please contact:
Media contact:
Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com
Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93
Investor Relations contacts:
Arthur Stril, Interim Chief Financial Officer, +1 (347) 809 5980, investors@cellectis.com
Attachment
FAQ
How many shares does Cellectis (CLLS) have in circulation as of January 2025?
What is the total number of voting rights for CLLS stock as of January 2025?
What is the difference between CLLS total shares and voting rights in January 2025?
On which exchange market are CLLS shares listed according to the January 2025 update?
